SUPERB.

Trial name or title	Heparin‐bonded edoluminal versus surgical femoropopliteal bypass; a multicentre randomized controlled trial
Methods	Allocation: randomised Endpoint classification: safety/efficacy study Intervention model: parallel assignment Masking: open label Primary purpose: treatment
Participants	Individuals with symptomatic PAD of the SFA with a Rutherford category 3 to 6
Interventions	Heparin‐bonded ePTFE endoluminal femoro‐popliteal bypass versus surgical femoro‐popliteal bypass
Outcomes	Primary outcome measures: primary (and assisted) patency; QoL Secondary outcome measures: secondary patency; complications; clinical improvement; reintervention; target lesion revascularization
Starting date	October 2010
Contact information	MMPJ Reijnen ‐ Tel.:+31260058888 ext 3154, email: mreijnen@alysis.nl MMA Lensvelt ‐ Tel.: +31641266258, email: superbtrial@gmail.com
Notes	NCT01220245 Sponsors and Collaborators: Rijnstate Hospital